Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

957

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Saxagliptin

5 mg, oral tablet, once daily

DRUG

Glimepiride

1, 2, 3, 4 or 6 mg, oral encapsulated tablet, once daily

Trial Locations (131)

Unknown

Research Site, Feldbach

Research Site, Graz

Research Site, Salzburg

Research Site, Vienna

Research Site, Aalborg

Research Site, Ans

Research Site, Kjellerup

Research Site, Kolding

Research Site, Nørresundby

Research Site, Roskilde

Research Site, Roslev

Research Site, Viborg

Research Site, Viby J

Research Site, Værløse

Research Site, Lahti

Research Site, Vantaa

Research Site, Harjavalta

Research Site, Helsinki

Research Site, Kuopio

Research Site, Kuusankoski

Research Site, Oulu

Research Site, Seinäjoki

Research Site, Sipoo

Research Site, Tampere

Research Site, Turku

Research Site, Vimpeli

Research Site, Châtellerault

Research Site, La Rochelle

Research Site, La Seyne-sur-Mer

Research Site, Laval

Research Site, Seysses

Research Site, Strasbourg

Research Site, Tiercé

Research Site, Hamburg

Research Site, Augsburg

Research Site, Darmstadt

Research Site, Dresden

Research Site, Essen

Research Site, Gelnhausen

Research Site, Hamburg

Research Site, Magdeburg

Research Site, Mayen

Research Site, München

Research Site, Neumünster

Research Site, Nuremberg

Research Site, Pirna

Research Site, Ratzeburg

Research Site, Reinfeld

Research Site, Sulzbach

Research Site, Athens

Research Site, Athens

Research Site, Nikaia

Research Site, Thessaloniki

Research Site, Ács

Research Site, Balatonfüred

Research Site, Budapest

Research Site, Érd

Research Site, Gyöngyös

Research Site, Komárom

Research Site, Milan

Research Site, Palermo

Research Site, Padua

Research Site, Pordenone

Research Site, Reggio Emilia

Research Site, Chieti

Research Site, Napoli

Research Site, Roma

Research Site, Viterbo

Research Site, Durango

Research Site, Guadalajara

Research Site, Monterrey

Research Site, Aksdal

Research Site, Ålesund

Research Site, Elverum

Research Site, Halden

Research Site, Hamar

Research Site, Kirkenær

Research Site, Kongsvinger

Research Site, Larvik

Research Site, Lierskogen

Research Site, Nordlenangen

Research Site, Oslo

Research Site, Røa

Research Site, Sandvika

Research Site, Skedsmokorset

Research Site, Svelvik

Research Site, Sørumsand

Research Site, Trondheim

Research Site, Ulset

Research Site, Seville

Research Site, Zamora

Research Site, A Coruña

Research Site, Begonte (lugo)

Research Site, Getafe

Research Site, Madrid

Research Site, San Sebastián de los Reyes

Research Site, Oviedo

Research Site, Alicante

Research Site, Jönköping

Research Site, Finspång

Research Site, Gävle

Research Site, Gothenburg

Research Site, Jarfalla

Research Site, Lessebo

Research Site, Lund

Research Site, Ödeshög

Research Site, Piteå

Research Site, Rättvik

Research Site, Stockholm

Research Site, Trollhättan

Research Site, Västervik

Research Site, Fowey

Research Site, Nr Penzance

Research Site, Penzance

Research Site, Barnstaple

Research Site, Plymouth

Research Site, Annan

Research Site, Canterbury

Research Site, Whitstable

Research Site, Frome

Research Site, Bradford-on-Avon

Research Site, Trowbridge

Research Site, Ayrshire

Research Site, Bath

Research Site, Cumbernauld

Research Site, Dundee

Research Site, Hamilton

Research Site, Middlesex

Research Site, Motherwell

Research Site, Somerset

Research Site, Wellingborough

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY